GSK to invest in new factories and drug R&D in Africa Reuters Non-communicable diseases like heart disease, lung disorders, diabetes and cancer are expected to account for 46 percent of all deaths in sub-Saharan Africa by 2030, up from 28 percent in 2008, according to the World Bank. GSK has been stepping up its ... |
